Research / ADI / Fundamental state Inspectable configuration
State dimensions Filing 0000006281-23-000031 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
202.39% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 88th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.42% · OPTIONAL · VALID
Operating cash generation 88th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
43.28% · OPTIONAL · VALID
Share-count growth 0th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.shares_outstanding
-3.34% · CORE · VALID
Revenue growth 54th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
21.06% · CORE · VALID
Inventory pressure 100th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
46.87% · OPTIONAL · VALID
Gross margin 29th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.gross_margin
65.37% · CORE · VALID
Operating margin 100th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.operating_margin
34.80% · CORE · VALID
R&D intensity 0th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
12.74% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.31% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Oct 30, 2021 9/9 normalized Level 3 Jan 29, 2022 9/10 normalized Level 3 Apr 30, 2022 9/10 normalized Level 3 Jul 30, 2022 9/10 normalized Level 3 Oct 29, 2022 9/9 normalized Level 3 Jan 28, 2023 9/10 normalized Level 3 Apr 29, 2023 9/10 normalized Level 3 Jul 29, 2023 9/10 normalized Level 3 Oct 28, 2023 9/10 normalized Level 3 Feb 3, 2024 9/10 normalized Level 3 May 4, 2024 10/10 normalized Level 3 Aug 3, 2024 10/10 normalized Level 3 Nov 2, 2024 10/10 normalized Level 3 Feb 1, 2025 10/10 normalized Level 3 May 3, 2025 10/10 normalized Level 3 Aug 2, 2025 10/10 normalized Level 3 Nov 1, 2025 10/10 normalized Level 3 Jan 31, 2026 10/10 normalized Level 3 May 2, 2026 10/10 normalized Level 3 Aug 1, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 5.82%
Current 5.42%
Delta -0.40% Cash Generation Increased
Previous 37.25%
Current 43.28%
Delta 6.02% Dilution Decreased
Previous -3.05%
Current -3.34%
Delta -0.28% Growth Decreased
Previous 64.16%
Current 21.06%
Delta -43.10% Inventory Pressure Increased
Previous 11.65%
Current 46.87%
Delta 35.21% Margin Increased
Previous 62.70%
Current 65.37%
Delta 2.67% Profitability Increased
Previous 27.29%
Current 34.80%
Delta 7.51% R And D Intensity Decreased
Previous 14.15%
Current 12.74%
Delta -1.41% Sbc Intensity Decreased
Previous 2.69%
Current 2.31%
Delta -0.38% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.